The platform, adopted by durable medical equipment organizations, uses AI agents to process referrals, prior authorizations, and claims to reduce administrative burdens.

Key takeaways:

Synthpop secured a $15 million Series A funding round led by Ansa Capital, bringing its total funding to $23 million.
The company’s artificial intelligence system automates up to 80% of healthcare business processes, including prior authorizations and claims, integrating directly with major EHR systems.
Durable medical equipment (DME) organizations are among those utilizing the platform to reduce workflow times from 40 minutes to under one minute.

Synthpop, a healthcare artificial intelligence (AI) company that builds automation tools to eliminate administrative bottlenecks in payer, provider, and patient operations, has raised $15 million in Series A funding.

The funding round, which brings the company’s total funding to $23 million, was led by Ansa Capital. Defy.vc and Peterson Ventures participated in the round, alongside Storm Ventures and strategic investor Bruce Broussard. Marco DeMeireles, co-founder and managing partner at Ansa, will join Synthpop’s board of directors.

The company’s platform unifies document intelligence, payer-aware reasoning, and conversational voice agents into a coordinated system designed to automate up to 80% of healthcare business processes. These AI agents integrate directly with electronic health record (EHR), billing, and e-prescribe platforms. Customers, including large organizations across the durable medical equipment (DME) sector, use the system to handle workflows ranging from referrals and prior authorizations to eligibility checks and claims follow-ups.

“Point solutions can’t fix operational bottlenecks,” says Elad Ferber, CEO of Synthpop, in a release. “Providers need a unified system that understands insurance requirements, handles phone calls naturally, and works seamlessly with their existing software. This funding helps us expand our coverage and deepen integrations so providers can scale their operations and expand access to care.”

Over the past year, Synthpop has processed more than 2 million patients and integrated with eight major EHR systems. According to the company, workflows that historically took 40 minutes are now processed in under one minute at a five times lower cost than traditional human labor spend, while maintaining compliance and transparency. Synthpop is SOC 2-audited and fully HIPAA compliant.

“Healthcare organizations have long been constrained by highly manual workflows and human capital bottlenecks. AI-native solutions like Synthpop are the only way for them to fulfill rising demand and increased patient expectations,” says DeMeireles, co-founder and managing partner at Ansa, in a release. “The early value delivered to customers has been extremely compelling; I’m thrilled to join the board and partner with Elad and the Synthpop team.”

The funding follows the recent addition of the airt team, led by Davor Runje and Hajdi Cenan, to accelerate Synthpop’s AI workflow capabilities. Synthpop will use the Series A funding to expand its team, deepen product capabilities, and expand into additional healthcare verticals.

“Synthpop stood out to us for its ability to automate complex, real-world healthcare workflows with speed, accuracy, and compliance,” says Medha Agarwal, general partner at Defy.vc, in a release. “Their multi-agent platform delivers immediate, measurable value for providers, dramatically reducing time, cost, and friction across the patient journey.”

Synthpop was founded in 2023 by Ferber and Jan Jannink, PhD, who serves as chief technology officer.